Connect with us

Technology

Ceretrieve Announces Groundbreaking Success in FIH Ischemic Stroke Cases

Published

on

Ceretrieve’s aspiration catheter demonstrated clots removal, completely restoring blood flow in a single pass.

YOKNEAM, Israel, May 28, 2024 /PRNewswire/ — Ceretrieve announced today the successful results of the company’s multicenter, single-arm study, showcasing the capabilities of its state-of-the-art aspiration catheter. The study, conducted across two centers, included 20 patients who suffered from acute ischemic stroke (AIS) due to intracranial large vessel occlusion (LVO) and were eligible for thrombectomy within 24 hours of symptom onset. The study was aimed for assessing the safety and initial performance of the Ceretrieve Device.

Redefining Stroke Treatment

Ceretrieve’s mission is to transform stroke care, save lives, minimize disability, and significantly improve post-stroke quality of life. Ceretrieve’s aspiration catheter is at the forefront of this mission, delivering aspiration capabilities that are far superior when compared to existing devices, allowing clot(s) removal in a single pass, while fully restoring blood flow. Designed for seamless integration within a conventional 6Fr delivery catheter, Ceretrieve’s device offers exceptional trackability and maneuverability, ensuring efficient access to the clot location.

As shown in the study conducted, Ceretrieve’s aspiration catheter not only excelled in performance but also ensured the highest safety standards by reducing the risk of releasing clot fragments further into the brain. In the first-in-human (FIH) study 80% Complete/Near-Complete Perfusion was achieved.

The study included two generations of the device, and the results with the improved Gen 2 device are highly impressive: 100% Complete/Near-Complete Perfusion achieved in all treated patients; and 83% First Pass Complete Perfusion (FPE mTICI 3), far exceeding the 30%-40% rate of current gold-standard devices.

Ceretrieve’s CEO, Maysa Mustafa: “The promising results of our clinical studies are the culmination of years of hard work and R&D. Our mission to redefine stroke treatment drives everything we do, and these results signify a major leap forward in saving and dramatically improving lives following an ischemic stroke.”

“The ‘first pass effect’ has been shown to improve patient outcomes” says Dr. Shady Jashan (Galilee Medical Center, Israel) who performed the first neuro thrombectomy procedure with the Ceretrieve device. “Our experience in FIH trials demonstrated that the Ceretrieve device quickly enables complete clot ingestion in first pass even for the most challenging clots and anatomies. This has the potential to dramatically improve patient clinical outcomes.”

Prof. Serder Geyik, MD (Florya Medical Park, Turkey): “The term ‘Everything comes with a price’ is not valid for the Ceretrieve device. Ceretrieve’s device aspirates the clot with a giant bore tip- double than the largest catheters in the market, for maximal vacuum effect without paying the price in trackability. In addition, it provides local flow restriction in the middle cerebral artery reducing distal emboli. It is the only device that includes all the features for successful thrombectomy and first pass effect in one single device. “

Amir Belson, M.D., Ceretrieve Chair: “With Ceretrieve’s advanced technology, we are seeing significant improvements in patient recovery rates. This innovation is setting a new standard in stroke care, offering patients better outcomes and real hope for recovery.”

About Ceretrieve

Ceretrieve’s vision is to be the doctor’s first-choice device in treating ischemic stroke offering complete treatment with superior performance in one device. Ceretrieve was established in 2017 in collaboration with The Trendlines Group (SGX:42T) (OTCQX: TRNLY), a leading investment group based in Israel and Singapore, as well as the Israel Innovation Authority (IIA) Incubators Program. Agriline and several angel investors are among the Company’s additional investors.

Contact:
Maysa Mustafa, CEO
maysa@ceretrieve.com

Photo – https://mma.prnewswire.com/media/2423407/Ceretrieve_case.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/ceretrieve-announces-groundbreaking-success-in-fih-ischemic-stroke-cases-302156754.html

SOURCE Ceretrieve

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

TECNO Named Among 2024-2025 Global Top 10 Smartphone Brands and Wins Dual Product Innovation Awards at CES 2025

Published

on

By

LAS VEGAS, Jan. 9, 2025 /PRNewswire/ — TECNO, a global innovative technology brand, celebrates a landmark achievement at CES 2025. The brand earned three awards: its selection as one of the 2024-2025 Global Top 10 Smartphone Brands, marking its third consecutive win, and recognition for its groundbreaking products, the PHANTOM V Fold2 5G and Pocket Go AR Handheld Gaming Device, which claimed prestigious product innovation awards.

The annual CES Global Top Brands Award and Product Innovation Awards, celebrates global consumer electronics brands leading in frontier innovations. This prestigious platform, often referred to as the “Oscars of the Global Consumer Electronics Industry,” recognizes the brands and products that have not only made a remarkable impact on the global market, but also set new standards for technology and consumer experience across the industry.

A Legacy of Innovation and Global Impact

“This achievement is a testament to our breakthroughs and accomplishments in building an intelligent product ecosystem. Each of the awarded products embodies a distinct aspect of our brand’s innovation: from cutting-edge AI advancements to transformative user experiences. These innovations enable us to accelerate the adoption of AI and emerging technologies in key markets, ensuring that consumers in emerging markets can fully benefit from the digital revolution.” said Guo Lei, General Manager of TECNO.

In the past year, TECNO took bold strides toward its AI-powered future, introducing a series of innovations- TECNO launched the newest PHANTOM foldable series, bringing practical AI-powered features and functions that make a real difference in people’s lives. By integrating advanced AI algorithms with extensive multi-skin tone database, TECNO launched an upgraded Universal Tone technology, further takes up the challenge of solving skin tone “color bias” in smartphone imaging and formed partnerships with top global universities such as Leeds University, Nanyang Technological University in Singapore and Dar Al – Hekma University in Saudi Arabia.

“TECNO exemplifies how global innovation can resonate locally,” said Zhu Dongfang, President of the Asian Digital Group, speaking on behalf of the jury. “Its commitment to making advanced technology accessible and impactful for emerging markets not only redefines the user experience but also cements its standing as a trailblazer in smart devices and AI innovation.”

TECNO PHANTOM V Fold2 5G: Winner of the AI-Powered Foldable Phone Innovation Award

The PHANTOM V Fold2 5G received the prestigious AI-Powered Foldable Phone Innovation Award, underscoring TECNO’s determination to reshape the foldable smartphone landscape.

Combining sleek design with powerful AI capabilities, the PHANTOM V Fold2 5G is an industry standout. Its ultra-thin profile—just 5.5mm when unfolded—sets a new standard for portability without sacrificing durability, thanks to its aviation-grade waterdrop hinge. Its 7.85-inch 2K AMOLED main screen and 6.42-inch curved AMOLED outer screen deliver immersive visuals, enhanced by Dolby Atmos surround sound for a premium multimedia experience.

Powered by TECNO’s Ella AI assistant, the device seamlessly integrates features like real-time translation, intelligent writing, and productivity tools, including the PHANTOM V Pen. This makes it an ideal companion for professionals seeking to blend creativity and efficiency.

TECNO Pocket Go: Winner of the Ultra-Portable AR PC Gaming Innovation Design Award

TECNO’s Pocket Go redefines portable gaming, winning the Ultra-Portable AR PC Gaming Innovation Design Award for its visionary integration of augmented reality (AR) with handheld gaming.

Weighing just 557 grams, Pocket Go delivers the immersive quality of a 215-inch TV projection in a compact, ultra-light design. Its VisionTrack technology leverages head tracking and AI algorithms to create an unmatched sensory gaming experience.

Powered by an AMD Ryzen™ 7 processor, Pocket Go excels in performance, handling AAA gaming titles seamlessly while offering replaceable battery design, and PC-level cooling mechanisms for uninterrupted play. Beyond gaming, the device transitions effortlessly to productivity, and multimedia tasks and multi-usages, reflecting TECNO’s dedication to creating versatile technology.

With Pocket Go, TECNO merges gaming innovation with AR technology to deliver an immersive and portable experience like no other, showcasing its ability to continuously explore new frontiers in connected living, as a industry leader setting new global standards.

TECNO’s momentous achievements at the CES Global Top Brands Awards and Product Innovation Awards highlight its consistent efforts to innovate while addressing the unique needs of emerging markets. Staying true to its “Stop at Nothing”spirit, TECNO continues to enhance productivity, unleash creativity and remains resolute in its mission to bridge the digital divide and bring transformative experiences to markets.

View original content to download multimedia:https://www.prnewswire.com/news-releases/tecno-named-among-2024-2025-global-top-10-smartphone-brands-and-wins-dual-product-innovation-awards-at-ces-2025-302346808.html

SOURCE TECNO Mobile Limited

Continue Reading

Technology

Redefining Charging: Anker Innovations Showcases Smart and Sustainable Solutions at CES

Published

on

By

BELLEVUE, Wash., Jan. 9, 2025 /PRNewswire/ — Anker Innovations, a global leader in mobile charging and consumer electronics, today unveiled its latest groundbreaking charging innovations at the Consumer Electronics Show (CES), held January 7-10 in Las Vegas. Among the featured products from Anker mobile charging and Anker SOLIX are the 25,000mAh Anker Power Bank, Anker 140W Charger, EverForest 2 Electric Cooler and Solar Umbrella, redefining fast-charging standards for users worldwide.

The products mentioned above will soon be available in Southeast Asia as well. “As the world’s No.1 mobile charging brand, we are grateful for the support of Southeast Asian consumers,” said Leon Wu, Head of Anker Innovations Southeast Asia. “Our mission is to ignite possibilities through ultimate innovation, and we are committed to providing products that exceed consumer expectations in Southeast Asia.”

Anker Innovations, a global leader in fast-charging technologies, develops products for home, office, and on-the-go charging. By integrating Gallium Nitride (GaN) technology and proprietary features, Anker delivers a safer, faster, and more sustainable charging experience. The Anker Prime Charging Docking Station (14-in-1, 160W) won the CES 2025 Innovation Award in the Computer Peripherals & Accessories category.

Anker 25,000mAh Power Bank (165W, Built-In and Retractable Cables)

Small in size and packed with the latest PD 3.0 technology, Anker’s fast-charging power bank delivers powerful performance.

Looking at Anker’s 25K 165W compact power bank, it boasts an impressive 25,000mAh capacity. Equipped with three USB-C ports and one USB-A port, it is ideal for charging multiple devices on the go. It can charge a MacBook Air 13′(M3) 2024 1.3 times, an iPhone 16 up to 4.5 times, and boost a MacBook Pro 16″ (M3) battery to 50% in just 33 minutes.

Notably, Anker’s 25,000mAh 165W power bank is the world’s first high-power power bank with retractable cables. It includes a 22cm cable and a 69cm retractable cable, this provides flexible charging options for users on the move while walking, sitting, or lying down.

With its smart TFT color screen and vibrant user interface, the power bank provides real-time data, including output power, power bank temperature and estimated charging time. Users can pull the retractable cable to trigger screen animations featuring dynamic emojis, adding a new level of convenience and fun.

Anker 140W Charger featuring First-Ever Digital Display

Anker’s charger breaks new ground as the first to feature a digital window display, bringing advanced functionality to the forefront. Users can easily check the total power output, output for each port, view the remaining power in real-time, monitor temperature, and track the total operation time for a more comprehensive overview.

Real-time temperature monitoring ensures device safety, while Anker’s advanced Active Shield 2.0 technology enhances the safety and reliability with up to 3 million daily safety checks. Built with aerospace-grade GaN, the charger maximizes performance for faster and more efficient charging.

Additionally, the four-port charger (3 USB-C and 1 USB-A) boasts sleek aesthetics and wall mounting capabilities.

Anker Prime 250W GaN Desktop Charger (6 Ports)

The Anker Prime 250W GaN Desktop Charger is a powerful 6-port solution designed for modern multi-device users. With 4 USB-C ports and 2 USB-A ports, it offers up to 250W of total output, capable of charging multiple devices simultaneously, from smartphones to laptops. Its standout feature is the 140W max power delivery for MacBook Pro users, fully charging a 16″ MacBook Pro in under two hours via PD3.1 technology.

A key feature is the 2.3″ LCD display, which shows real-time power output for each port and can be turned off manually or automatically. The twist button control allows users to view port details, adjust priorities, and switch between power modes with ease. This GaN-based charger combines high power, compact design, and smart control, making it the ideal charging solution for professionals and tech enthusiasts alike.

Leading the Future of Charging Technology

Anker’s new line of high-speed USB-C chargers are available exclusively on apple.com and at select Apple Store locations worldwide, designed to meet a variety of charging needs and can efficiently charge Apple Watches, AirPods, iPhones, iPads, MacBooks, and more, making them the perfect companion for Apple devices.

As a global pioneer in charging technologies, Anker continues to push the boundaries of what’s possible. Featuring cutting-edge GaN technology, these latest products deliver faster speeds, reduced heat generation, and more compact designs compared to traditional silicon-based chargers.

More importantly, these innovations are designed with user insights in mind, transforming charging devices from cold hardware into interactive and connected ecosystems, solidifying Anker’s status as a leader in next-generation charging technology.

In the near future, Anker plans to bring its Prime series—the most advanced multi-device fast charging lineup—along with its cutting-edge innovations to more users across Southeast Asian countries.

About Anker

Anker is the world’s #1 mobile charging brand and a developer of high-speed charging technologies for the home, car, and on the go. This includes wall plugs, wireless chargers, car chargers, power banks, cables, and more. Find out more about Anker at anker.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/redefining-charging-anker-innovations-showcases-smart-and-sustainable-solutions-at-ces-302345972.html

SOURCE Anker Innovations

Continue Reading

Technology

Implantica announces new exceptional published data from the largest real-world study from Germany

Published

on

By

VADUZ, Liechtenstein, Jan. 9, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces the journal Surgery Open Science, affiliated with the prestigious journal Surgery, recently published the largest real-world study from Germany, “A retrospective study assessing RefluxStop surgery for gastroesophageal reflux disease: Clinical outcomes in 79 patients from Germany“.

This first-of-its-kind real-world study from Germany’s leading Reflux center involving 79 patients for up to 17 months follow-up was led by Priv.-Doz. Dr. Thorsten G. Lehmann, MHBA – Center Director and Chief Physician of the Clinic for General and Visceral Surgery Friedrichshafen in southern Germany.

Dr. Lehmann’s study conclusion presented medical treatment with PPI reduced from 94.9% (before surgery) to 2.5% (after surgery) at follow-up. The study results show outstanding safety and effectiveness results demonstrating significant improvements both in PPI use and in quality of life, showing median improvements in GERD-HRQL (Gastro-Esophageal Reflux Disease – Health-Related Quality-of-Life) score of 100% and mean improvements of 92.4%. These outstanding outcomes are especially encouraging as half of study participants had either large hiatal hernia, >3 cm, or reoperation for previously failed anti-reflux surgery, both groups typically experience much higher complication rates.

Founder and CEO of Implantica, Dr. Peter Forsell says, “I am always humbled by the independent surgeons who continue to choose to gather and report RefluxStop™ data. Priv.-Doz. Dr. Lehmann’s data is yet another confirmation of the fantastic results one can achieve with the RefluxStop™ treatment. Remarkable results have now been reported by many independent centers across Europe showing similar exceptional safe and effective outcomes. With more than 1000 patients treated in Europe over the past five years, this study marks yet another great milestone demonstrating RefluxStop’s potential to revolutionize the GERD treatment landscape for millions of patients around the World.”

For further information, please contact:
Nicole Pehrsson, Chief Corporate Affairs Officer
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company’s Certified Adviser is FNCA Sweden AB, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on January 09, 2025, at 08:30 a.m. (CET).

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energizing platform designed to power remote-controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

About RefluxStop™

RefluxStop™ is a new innovative treatment that has the potential to spur a paradigm shift in anti-reflux surgery. It’s unique mechanism of action differentiates it from standard of care and current surgical solutions. Longer established surgical options for GORD involve encircling the food passageway to support the lower oesophageal sphincter’s closing mechanism and are commonly associated with side effects such as swallowing difficulties, pain when swallowing and inability to belch and/or vomit.

In contrast, the RefluxStop™ device treats the cause of acid reflux without encircling and putting pressure on the food passageway. It restores and maintains the lower oesophageal sphincter in its original, natural position.

The RefluxStop™ mechanism of action is focused on reconstructing all three components of the anti-reflux barrier, that if compromised could possibly result in acid reflux. It restores and supports the natural anatomical physiology of the body allowing the body to itself solve the problem with acid reflux.

Newsroom
https://www.implantica.com/media/media-kit

Community
https://ch.linkedin.com/company/implantica
https://www.twitter.com/implantica

Media Contact:
Implantica AG
Juanita Eberhart, VP Marketing & Advocacy
M: +1 925-381-4581
juanita.eberhart@implantica.com

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/implantica/r/implantica-announces-new-exceptional-published-data-from-the-largest-real-world-study-from-germany,c4089263

The following files are available for download:

https://mb.cision.com/Main/19732/4089263/3197605.pdf

Implantica announces new exceptional published data from the largest real-world study from Germany

https://news.cision.com/implantica/i/logo-transparent-1-8,c3366854

logo transparent 1 8

https://news.cision.com/implantica/i/reluxstop-product,c3366855

ReluxStop Product

 

View original content:https://www.prnewswire.co.uk/news-releases/implantica-announces-new-exceptional-published-data-from-the-largest-real-world-study-from-germany-302346814.html

Continue Reading

Trending